N@N

Naked Short Web Site Announces NRIFF, NDVLY, HDLM, GLOB Have Been Removed From Threshold Lists Today

^{Published on 2009-11-03 10:34:50, Last Modified on 2010-12-22 17:25:51 - WOPRAI}
 

November 3, 2009 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists. Nuvo Research (OTC: NRIFF), New World Development Co (OTC: NDVLY), Handleman (OTC: HDLM) and Global Med Technologies (OTCBB: GLOB). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

Nuvo Research Inc. (OTC: NRIFF) primarily focuses on the research and development of drug products that are delivered to and through the skin in Canada. It develops drugs based on two technology platforms, transdermal drug delivery and immune system regulation. The companya�s lead products include Pennsaid, a topical non-steroidal anti-inflammatory drug, which is used to treat the pain and symptoms of osteoarthritis of the knee; and Pennsaid Plus, a pre clinical stage product used for applications in various therapeutic areas. Nuvo Research Inc. markets its Pennsaid products in Canada and the Caribbean, as well as in European countries, such as Greece, Italy, and the United Kingdom. Its products also comprise Oxoferin, a topical wound healing agent; and WF10, a chlorite-based, immunomodulating drug, which is in the Phase II clinical trial used for the treatment of inoperable pancreatic cancer. It markets its Oxoferin drug in Europe, Asia, and South America under the Oxoferin and Oxovasin trade names. The company was formerly known as Dimethaid Research, Inc. and changed its name to Nuvo Research Inc. in September 2005. Nuvo Research Inc. was founded in 1983 and is headquartered in Mississauga, Canada. There is no longer a failure to deliver in shares of NRIFF.

New World Development Company Limited (OTC: NDVLY), an investment holding company, engages in the property investment, development, and management businesses in Hong Kong, Mainland China, and Macau. Its property portfolio comprises shopping malls, offices, hotels, and service apartments. The companya�s infrastructure operations include operation of toll roads, power plants, water treatment, and waste management plants, as well as logistics and warehousing services. It also provides facilities management, contracting and transport, financial services, and telecommunication services, as well as operates department stores, and hotel and restaurant. In addition, the company engages in the investment consultancy business; generation and supply of electricity; operation of rail container terminal and related business; wholesale assembly and storage of fuel; manufacture and distribution of distilled water; development, operation, and management of pier and related business; and operation of pharmaceutical stores. Further, it involves in bond issuing; operation of wireless telecommunication networks, toll tunnel, golf clubs and resorts, and hostels; used cars trading; mechanical, civil, and electrical engineering; and foundation works. Additionally, the company engages in the provision of heat transfer devices and pressure vessel components; car park management and rental operations; piling and ground investigation business; the sale of duty-free liquor and tobacco; building construction; and landscaping and project contracting operations. It also engages in project management; ceramic tiles retail trade; trading system integration products, motor vehicles, and building and engineering materials; and elderly care services, laundry, cleaning and pest control, management, consultancy, insurance broking, ticketing, nominee, security, advertising and media, and information technology solutions and services businesses. The company was founded in 1970 and is based in Central, Hong Kong. There is no longer a failure to deliver in shares of NDVLY.

Handleman Company (OTC: HDLM) does not have significant operations. The company is considering a plan of liquidation. Previously, it operated as a category manager and distributor of prerecorded music, as well as console video game hardware, software, and accessories to retailers in the United States, the United Kingdom, and Canada. The company was founded in 1934 and is headquartered in Troy, Michigan. There is no longer a failure to deliver in shares of HDLM.

Global Med Technologies, Inc. (OTCBB: GLOB) designs, develops, markets, and supports information management software products for blood banks, hospitals, centralized transfusion centers, and other health care related facilities. Its products include SafeTrace, which is used to assist community blood centers, hospitals, plasma centers, and outpatient clinics for the collection and management of blood and blood products; SafeTrace Tx, a transfusion management information system designed for hospitals and centralized transfusion centers to enable the quality of blood transfused into patient-recipients; and ElDorado Donor, a blood management software application designed to provide the information system needs of blood banks and donor centers. The company, through its subsidiary, Inlog S.A. offers EdgeBlood, a product for the donor center market; EdgeTrace for the hospital transfusion market; EdgeLab, a laboratory information system; EdgeCell, a cellular therapy for tissue banks, stem cell centers, and cord blood centers; and SAPA, a regulatory compliance and document management solution. It also provides PeopleMed, a system that coordinates sources of information and users of a patienta�s clinical information, including laboratory, pharmacy, primary and specialty care providers, claims, and medical records, as well as validation services, such as documenting and testing systems. In addition, the company involves in licensing software; the provision of maintenance, consulting, and support services; and in the resale of software obtained from vendors. It operates in the United States, Canada, the Caribbean, the European Union, Africa, French Polynesia, and New Caledonia. Global Med Technologies, Inc. was founded in 1989 and is based in Lakewood, Colorado. There is no longer a failure to deliver in shares of GLOB.

BUYINS.NET, www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net